Work

Abstract B48: Design of effective combination therapies for high-grade serous ovarian cancer using patient-derived xenograft models.

Year: 2016

Type: conference-abstract

Source: Clinical Cancer Research

DOI: 10.1158/1557-3265.ovca15-b48

Authors: Claudia Iavarone, Ioannis Zervantonakis, Hsing-Yu Chen, Sangeetha S. Palakurthi, Joyce Fu Liu, Ursula A. Matulonis, Ronny I. Drapkin, Gordon B. Mills, Joel D. Leverson, Deepak Sampath, Joan S. Brugge

Institutions: Harvard University, Dana-Farber Cancer Institute, University of Pennsylvania, The University of Texas MD Anderson Cancer Center, AbbVie (United States), Genentech

Language: English

Topic: Ovarian cancer diagnosis and treatment

Subfield: Reproductive Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2397558680

Cites:

Cited by:

Related to: 10